12 Oct CBD vs THC for Pain

It was originally thought that tetrahydrocannabinol (THC) provided the majority of benefits from the cannabis plant. However, it is now becoming clear that there is another beneficial compound found in cannabis called cannabidiol (CBD) and it provides the same medical properties of marijuana without the high. In-fact CBD oil does not have any known negative side effects at all, even when taken in large doses. This means that its benefits can be felt by everyone. The compound has many applications, especially when it comes to pain relief and helping to manage chronic pain.

CBD reduces nausea and vomiting. This has commonly been seen as one THC’s major benefits, and the reason why cannabis has been perscribed to patients undergoing chemotherapy for years. Now CBD Oil provides the same relief without any of THC’s psychoactive properties.

CBD Oil can be used to help alleviate suffering from chronic pain and provides relief from headaches, migraines, joint and muscle pain, especially arthritis and post-operation pain, nausea and dizziness as well as many other forms of pain.

CBD is the most common cannabinoid found in marijuana after THC. Varieties of the plant that have been grown to promote THC strength often have low levels of CBD. CBD Oil derived from hemp plants provide a much higher CBD content. High CBD plants provide very strong remedial benefits without the psychoactive nature of plants grown for their THC content. There is no confusion, elation or lethargy that THC often induces.

There does not appear to be many downsides from using CBD Hemp Oil – even on a daily basis. There are some rumors that high doses may temporarily slow the action of P450 liver enzymes, which help to metabolize drugs, however this is minor and temporary side effect. CBD simply slows the enzymes down1. The vast majority of studies show CBD to be safe even in large doses. This is excellent news because the cannabinoid CBD shows “great promise for the treatment of Alzhiemer’s, Parkinson’s disease, and all neurodegenerative-related diseases.”2